Harli Grant
Overview
Explore the profile of Harli Grant including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
223
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Pina-Escudero S, La Joie R, Spina S, Hwang J, Miller Z, Huang E, et al.
Alzheimers Dement (Amst)
. 2024 Jul;
16(3):e12602.
PMID: 39040464
Introduction: Alzheimer's disease (AD) neuropathological changes present with amnestic and nonamnestic (atypical) syndromes. The contribution of comorbid neuropathology as a substratum of atypical expression of AD remains under investigated. Methods:...
2.
Padula C, Ball S, Wyman M, Evans K, Grant H, Periyakoil V, et al.
Alzheimers Dement
. 2024 Feb;
20(4):3088-3098.
PMID: 38348782
Introduction: Older military veterans often present with unique and complex risk factors for Alzheimer's disease (AD) and related dementias. Increasing veteran participation in research studies offers one avenue to advance...
3.
Mantyh W, Cochran J, Taylor J, Broce I, Geier E, Bonham L, et al.
Alzheimers Dement (Amst)
. 2023 Oct;
15(4):e12482.
PMID: 37780862
Early-onset Alzheimer's disease (AD) is highly heritable, yet only 10% of cases are associated with known pathogenic mutations. For early-onset AD patients without an identified autosomal dominant cause, we hypothesized...
4.
Asken B, Tanner J, Gaynor L, VandeVrede L, Mantyh W, Casaletto K, et al.
Alzheimers Res Ther
. 2023 Jul;
15(1):126.
PMID: 37480088
Background: Traumatic encephalopathy syndrome (TES) is a clinical phenotype sensitive but non-specific to underlying chronic traumatic encephalopathy (CTE) neuropathology. However, cognitive symptoms of TES overlap with Alzheimer's disease (AD), and...
5.
Snyder A, Grant H, Chou A, Lindbergh C, Kramer J, Miller B, et al.
Alzheimers Dement
. 2023 Feb;
19(8):3339-3349.
PMID: 36791265
Introduction: Immune dysfunction is important in aging and neurodegeneration; lacking clinically available tools limits research translation. We tested associations of cerebral spinal fluid (CSF) monocyte-to-lymphocyte ratio (MLR)-innate immune activation surrogate-with...
6.
Asken B, Tanner J, VandeVrede L, Casaletto K, Staffaroni A, Mundada N, et al.
J Neurotrauma
. 2022 Apr;
39(17-18):1195-1213.
PMID: 35481808
Traumatic encephalopathy syndrome (TES) criteria were developed to aid diagnosis of chronic traumatic encephalopathy (CTE) pathology during life. Interpreting clinical and biomarker findings in patients with TES during life necessitates...
7.
Falgas N, Allen I, Spina S, Grant H, Pina Escudero S, Merrilees J, et al.
Eur J Neurol
. 2021 Dec;
29(4):957-967.
PMID: 34862834
Background And Purpose: The faster rates of cognitive decline and predominance of atypical forms in early-onset Alzheimer's disease (EOAD) suggest that neuropsychiatric symptoms could be different in EOAD compared to...
8.
Toller G, Zitser J, Sukhanov P, Grant H, Miller B, Kramer J, et al.
Neurocase
. 2021 Aug;
28(1):19-28.
PMID: 34402746
The most common neurodegenerative syndrome associated with Pick's disease pathology (PiD) is behavioral variant frontotemporal dementia (bvFTD), which features profound social behavioral changes. Rarely, PiD can manifest as an Alzheimer's...
9.
Edwards L, La Joie R, Iaccarino L, Strom A, Baker S, Casaletto K, et al.
Neurobiol Aging
. 2021 May;
105:86-98.
PMID: 34049062
We assessed sex differences in amyloid- and tau-PET retention in 119 amyloid positive patients with mild cognitive impairment or Alzheimer's disease (AD) dementia. Patients underwent 3T-MRI, C-PIB amyloid-PET and F-Flortaucipir...
10.
Spina S, La Joie R, Petersen C, Nolan A, Cuevas D, Cosme C, et al.
Brain
. 2021 Mar;
144(7):2186-2198.
PMID: 33693619
Co-pathologies play an important role in the expression of the Alzheimer's disease clinical phenotype and may influence treatment efficacy. Early-onset Alzheimer's disease, defined as manifesting before age 65, is viewed...